Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Trainer

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|January 1, 2004
High levels of 150-kDa insulin-like growth factor binding protein three ternary complex in patients with acromegaly and the effect of pegvisomant-induced serum IGF-I normalizationCraig Parkinson, Allan Flyvbjerg, Peter J Trainer
Journal of Neuroendocrinology|January 11, 2003
Pituitary tumour therapy: using the biologyJulian R E Davis, Peter J Trainer
Pituitary|April 6, 2007
IGF-I measurements in the monitoring of GH therapyClaire E Higham, Andreas Jostel, Peter J Trainer
Nature Reviews. Endocrinology|August 15, 2012
Regulation of cortisol bioavailability--effects on hormone measurement and actionIlias Perogamvros, David W Ray, Peter J Trainer
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 11, 2014
The harmonisation of growth hormone measurements: taking the next stepsGilbert E Wieringa, Catharine M Sturgeon, Peter J Trainer
European Journal of Endocrinology|January 15, 2009
Pituitary-independent effect of octreotide on IGF1 generationAna Pokrajac, Jan Frystyk, Allan Flyvbjerg, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|May 12, 2004
The place of pegvisomant in the acromegaly treatment algorithmAngela N Paisley, Peter J Trainer, William M Drake
The Journal of Clinical Endocrinology and Metabolism|November 2, 2006
Gender, body weight, disease activity, and previous radiotherapy influence the response to pegvisomantCraig Parkinson, Pia Burman, Michael Messig, et al.
Hormones (Athens, Greece)|July 19, 2015
Intractable hypoglycaemia in a patient with advanced carcinoid syndrome successfully treated with hepatic embolizationAngelos Kyriacou, Was Mansoor, Jeremy Lawrance, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|May 13, 2019
New causes of hypophysitisKevin C J Yuen, Vera Popovic, Peter J Trainer
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|January 1, 2004
High levels of 150-kDa insulin-like growth factor binding protein three ternary complex in patients with acromegaly and the effect of pegvisomant-induced serum IGF-I normalizationCraig Parkinson, Allan Flyvbjerg, Peter J Trainer
Journal of Neuroendocrinology|January 11, 2003
Pituitary tumour therapy: using the biologyJulian R E Davis, Peter J Trainer
Pituitary|April 6, 2007
IGF-I measurements in the monitoring of GH therapyClaire E Higham, Andreas Jostel, Peter J Trainer
Nature Reviews. Endocrinology|August 15, 2012
Regulation of cortisol bioavailability--effects on hormone measurement and actionIlias Perogamvros, David W Ray, Peter J Trainer
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 11, 2014
The harmonisation of growth hormone measurements: taking the next stepsGilbert E Wieringa, Catharine M Sturgeon, Peter J Trainer
European Journal of Endocrinology|January 15, 2009
Pituitary-independent effect of octreotide on IGF1 generationAna Pokrajac, Jan Frystyk, Allan Flyvbjerg, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|May 12, 2004
The place of pegvisomant in the acromegaly treatment algorithmAngela N Paisley, Peter J Trainer, William M Drake
The Journal of Clinical Endocrinology and Metabolism|November 2, 2006
Gender, body weight, disease activity, and previous radiotherapy influence the response to pegvisomantCraig Parkinson, Pia Burman, Michael Messig, et al.
Hormones (Athens, Greece)|July 19, 2015
Intractable hypoglycaemia in a patient with advanced carcinoid syndrome successfully treated with hepatic embolizationAngelos Kyriacou, Was Mansoor, Jeremy Lawrance, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|May 13, 2019
New causes of hypophysitisKevin C J Yuen, Vera Popovic, Peter J Trainer
Pageof 6